(Q40133437)

17 September 2017

title

Analysis of Tim-3 as a therapeutic target in prostate cancer (English)

1 reference

17 September 2017

Yongrui Piao

1

1 reference

17 September 2017

Xuanshun Jin

series ordinal

2

1 reference

17 September 2017

publication date

1 July 2017

1 reference

17 September 2017

1 reference

17 September 2017

volume

39

1 reference

17 September 2017

issue

7

1 reference

17 September 2017

page(s)

1010428317716628

1 reference

17 September 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

Prostate cancer research in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

Association between integrin expression and prognosis in localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

Tim-3, a negative regulator of anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

Therapeutic gene modified cell based cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

Emerging Tim-3 functions in antimicrobial and tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

The expression of Tim-3 in peripheral blood of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

Tim-3 on peripheral CD4⁺ and CD8⁺ T cells is involved in the development of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1010428317716628

21 January 2018

Identifiers

DOI

10.1177/1010428317716628

1 reference

17 September 2017

1 reference